Department of Physiology, University of Arizona, Tucson, Arizona 85724, USA.
J Cell Physiol. 2011 Oct;226(10):2555-61. doi: 10.1002/jcp.22602.
Previous studies show Src family kinase (SFK) activation is involved in a response that stimulates Na,K-ATPase. Here, we tested whether SFK activation is involved in the Na,K-ATPase response to endothelin-1 (ET-1). Intact porcine lenses were exposed to 100 nM ET-1 for 5-30 min. Then, the epithelium was removed and used for Na,K-ATPase activity measurement and Western blot analysis of SFK activation. Na,K-ATPase activity was reduced by ∼30% in lenses exposed to ET-1 for 15 min. The response was abolished by the SFK inhibitor PP2 or the ET receptor antagonist, PD145065. Activation of a ∼61 kDa SFK was evident from an increase in Y416 phosphorylation, which reached a maximum at 15 min ET-1 treatment, and a decrease in Y527 phosphorylation. PP2 prevented SFK activation. Since Fyn, Src, Hck, and Yes may contribute to the observed 61 kDa band, these SFKs were isolated by immunoprecipitation and analyzed. Based on Y416 phosphorylation, ET-1 appeared to activate Fyn, while Src and Hck were inhibited and Yes was unaltered. ET-1 requires SFK activation to cause Na,K-ATPase inhibition. ET-1 elicits a different pattern of SFK activation from that reported earlier for purinergic agonists that stimulate Na,K-ATPase activity and activate Src. In the ET-1 response Src is inhibited and Fyn is activated. The findings suggest SFK phosphorylation is involved in a regulatory mechanism for Na,K-ATPase. Knowing this may help us understand drug actions on Na,K-ATPase. Faulty regulation of Na,K-ATPase in the lens could contribute to cataract formation since an abnormal sodium content is associated with lens opacification.
先前的研究表明,Src 家族激酶 (SFK) 的激活参与了刺激 Na,K-ATPase 的反应。在这里,我们测试了 SFK 的激活是否参与了内皮素-1 (ET-1) 对 Na,K-ATPase 的反应。完整的猪晶状体暴露于 100 nM ET-1 中 5-30 分钟。然后,去除上皮并用于 Na,K-ATPase 活性测量和 SFK 激活的 Western blot 分析。暴露于 ET-1 15 分钟的晶状体中,Na,K-ATPase 活性降低了约 30%。SFK 抑制剂 PP2 或 ET 受体拮抗剂 PD145065 可消除该反应。通过 Y416 磷酸化的增加,SFK 的约 61 kDa 被激活,这在 ET-1 处理 15 分钟时达到最大值,并且 Y527 磷酸化减少。PP2 阻止了 SFK 的激活。由于 Fyn、Src、Hck 和 Yes 可能对观察到的 61 kDa 带有所贡献,因此通过免疫沉淀分离这些 SFK 并进行分析。根据 Y416 磷酸化,ET-1 似乎激活了 Fyn,而 Src 和 Hck 受到抑制,Yes 则没有改变。ET-1 需要 SFK 激活来引起 Na,K-ATPase 抑制。ET-1 引发的 SFK 激活模式与先前报道的刺激 Na,K-ATPase 活性和激活 Src 的嘌呤能激动剂不同。在 ET-1 反应中,Src 被抑制,而 Fyn 被激活。研究结果表明,SFK 磷酸化参与了 Na,K-ATPase 的调节机制。了解这一点可能有助于我们理解药物对 Na,K-ATPase 的作用。晶状体中 Na,K-ATPase 的调节失常可能导致白内障形成,因为异常的钠离子含量与晶状体混浊有关。